Remove Compounding Remove Diabetes Remove Medical Schools
article thumbnail

Semaglutide and Tirzepatide Lead the Way in Comprehensive Diabetes and Obesity Management

Pharmacy Times

Semaglutide shows superior cardiovascular and renal benefits, with FDA-approved indications for reducing major adverse cardiovascular events and chronic kidney disease progression.

article thumbnail

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Pharmacy Times

Perioperative treatment should be tailored today based on individual clinical and genomic features for patients with EGFR - and ALK -type [NSCLC],” concluded Biagio Ricciuti, MD, PhD, from the Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

8. The Entrepreneurial Life of Dr. Richard Harris, a Pharmacist, Physician, and Business Mastermind

The Physician Pharmacist

The MCAT: Everything You Need To Know How Hard is Medical School Can you work while in Medical School? The Physician Pharmacist Do's and Don'ts 6 Most Common Questions About Transitioning From Pharmacy to Medicine The Art of Applying to Medical School (The Pharmacy Student Edition)! And in medical school.

article thumbnail

How to Lose Weight With Hashimoto’s

The Thyroid Pharmacist

Taking thyroid medications that contain T3 will help ensure that the right hormone is getting to the right receptors. Some report more weight loss with T4/T3 combinations (Armour*, Nature-Throid, compounded medications) versus T4 medications (Synthroid, Levoxyl, Tirosint) alone. J Clin Diagn Res. 2013;7(8):1764-1766.